Search research articles
Contact Us
Filters
Showing results (121-130 of 151) with videos related to
Page
of 16
Sort By:
Leukemia
|
March 25, 2018
Health-related quality of life in lower-risk MDS patients compared with age- and sex-matched reference populations: a European LeukemiaNet study
Reinhard Stauder, Ge Yu, Karin A Koinig, et al.
Leukemia & Lymphoma
|
April 19, 2019
A prospective non-interventional study on the impact of transfusion burden and related iron toxicity on outcome in myelodysplastic syndromes undergoing allogeneic hematopoietic cell transplantation<sup>.</sup>
Eline M P Cremers, Theo de Witte, Liesbeth de Wreede, et al.
British Journal of Haematology
|
April 25, 2015
Validation of the revised international prognostic scoring system (IPSS-R) in patients with lower-risk myelodysplastic syndromes: a report from the prospective European LeukaemiaNet MDS (EUMDS) registry
Louise de Swart, Alex Smith, Thomas W Johnston, et al.
Haematologica
|
November 5, 2017
Outcome after relapse of myelodysplastic syndrome and secondary acute myeloid leukemia following allogeneic stem cell transplantation: a retrospective registry analysis on 698 patients by the Chronic Malignancies Working Party of the European Society of Blood and Marrow Transplantation
Christoph Schmid, Liesbeth C de Wreede, Anja van Biezen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 16, 2013
Sequential combination of gemtuzumab ozogamicin and standard chemotherapy in older patients with newly diagnosed acute myeloid leukemia: results of a randomized phase III trial by the EORTC and GIMEMA consortium (AML-17)
Sergio Amadori, Stefan Suciu, Roberto Stasi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 11, 2016
Allogeneic Stem Cell Transplantation for Patients Age ≥ 70 Years with Myelodysplastic Syndrome: A Retrospective Study of the MDS Subcommittee of the Chronic Malignancies Working Party of the EBMT
Silke Heidenreich, Dimitris Ziagkos, Liesbeth C de Wreede, et al.
Annals of Hematology
|
November 25, 2015
Decitabine improves progression-free survival in older high-risk MDS patients with multiple autosomal monosomies: results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Group
Michael Lübbert, Stefan Suciu, Anne Hagemeijer, et al.
Blood Advances
|
January 4, 2018
Haploidentical transplant in patients with myelodysplastic syndrome
Marie Robin, Raphael Porcher, Fabio Ciceri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 3, 2018
HLA-Mismatched Donors in Patients with Myelodysplastic Syndrome: An EBMT Registry Analysis
Marie Robin, Raphaël Porcher, Annalisa Ruggeri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 7, 2016
Comparison of Intensive Chemotherapy and Hypomethylating Agents before Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndromes: A Study of the Myelodysplastic Syndrome Subcommittee of the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplant Research
Victoria T Potter, Simona Iacobelli, Anja van Biezen, et al.
Page
of 16
Search research articles
Search
Showing results (121-130 of 151) with videos related to
Sort By:
Page
of 16
Leukemia
|
March 25, 2018
Health-related quality of life in lower-risk MDS patients compared with age- and sex-matched reference populations: a European LeukemiaNet study
Reinhard Stauder, Ge Yu, Karin A Koinig, et al.
Leukemia & Lymphoma
|
April 19, 2019
A prospective non-interventional study on the impact of transfusion burden and related iron toxicity on outcome in myelodysplastic syndromes undergoing allogeneic hematopoietic cell transplantation<sup>.</sup>
Eline M P Cremers, Theo de Witte, Liesbeth de Wreede, et al.
British Journal of Haematology
|
April 25, 2015
Validation of the revised international prognostic scoring system (IPSS-R) in patients with lower-risk myelodysplastic syndromes: a report from the prospective European LeukaemiaNet MDS (EUMDS) registry
Louise de Swart, Alex Smith, Thomas W Johnston, et al.
Haematologica
|
November 5, 2017
Outcome after relapse of myelodysplastic syndrome and secondary acute myeloid leukemia following allogeneic stem cell transplantation: a retrospective registry analysis on 698 patients by the Chronic Malignancies Working Party of the European Society of Blood and Marrow Transplantation
Christoph Schmid, Liesbeth C de Wreede, Anja van Biezen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 16, 2013
Sequential combination of gemtuzumab ozogamicin and standard chemotherapy in older patients with newly diagnosed acute myeloid leukemia: results of a randomized phase III trial by the EORTC and GIMEMA consortium (AML-17)
Sergio Amadori, Stefan Suciu, Roberto Stasi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 11, 2016
Allogeneic Stem Cell Transplantation for Patients Age ≥ 70 Years with Myelodysplastic Syndrome: A Retrospective Study of the MDS Subcommittee of the Chronic Malignancies Working Party of the EBMT
Silke Heidenreich, Dimitris Ziagkos, Liesbeth C de Wreede, et al.
Annals of Hematology
|
November 25, 2015
Decitabine improves progression-free survival in older high-risk MDS patients with multiple autosomal monosomies: results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Group
Michael Lübbert, Stefan Suciu, Anne Hagemeijer, et al.
Blood Advances
|
January 4, 2018
Haploidentical transplant in patients with myelodysplastic syndrome
Marie Robin, Raphael Porcher, Fabio Ciceri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 3, 2018
HLA-Mismatched Donors in Patients with Myelodysplastic Syndrome: An EBMT Registry Analysis
Marie Robin, Raphaël Porcher, Annalisa Ruggeri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 7, 2016
Comparison of Intensive Chemotherapy and Hypomethylating Agents before Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndromes: A Study of the Myelodysplastic Syndrome Subcommittee of the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplant Research
Victoria T Potter, Simona Iacobelli, Anja van Biezen, et al.
Page
of 16